We are live on ! Find out more
BBP icon

Virtus Biotech ETF

14 hedge funds and large institutions have $3.68M invested in Virtus Biotech ETF in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

172% more capital inflows, than outflows

Capital inflows: $1.64M | Capital outflows: $604K

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

17% more funds holding

Funds holding: 12 → 14 (+2)

2.83% more ownership

Funds ownership: 15.74% → 18.58% (+2.8%)

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BBP Hedge Fund Activity: Q1 2024 in Review

14 of the 6,968 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q1 2024, worth a combined $3.68M — up 34% from $2.74M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new BBP positions and 3 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Raymond James Financial Services Advisors, opening a new position worth an estimated $500K. The largest seller was Susquehanna International Group, cutting an estimated $540K.

  • 14 institutional investors held Virtus Biotech ETF (BBP) as of Q1 2024, up from 12 in Q4 2023.
  • Funds reported $3.68M of Virtus Biotech ETF stock for Q1 2024, up 34% quarter-over-quarter.
  • 5 funds opened new Virtus Biotech ETF positions in Q1 2024 and 3 closed out, a net change of +2 holders.
  • The largest Virtus Biotech ETF buyer in Q1 2024 was Raymond James Financial Services Advisors, an estimated $500K added.
  • The largest Virtus Biotech ETF seller in Q1 2024 was Susquehanna International Group, an estimated $540K sold.

Based on aggregated 13F filings for Q1 2024.